PFIZER'S

OpenCalais Metadata: Ticker

PFE

OpenCalais Metadata: LegalName

PFIZER INC.

Bulgaria wants Brussels to Buy Out its Unneeded Vaccines against COVID-19

Bulgaria, Poland, Lithuania and Hungary insist on renegotiating the conditions for the supply of Pfizer's vaccines against COVID-19, according to a joint statement of their health ministers, quoted by the BTA correspondent in Brussels.

According to the announcement, they submitted their position to the EU Council of Health Ministers, which is meeting on Tuesday in Brussels.

China’s health system faces raft of challenges as Omicron hits

China is battling its biggest spike in coronavirus cases since the start of the pandemic, with millions under lockdown and the healthcare system feeling the pressure.

One of the last countries sticking to a zero-Covid strategy, China aims to stamp out every infection with strict lockdowns and by sending all cases to secure facilities.

Bulgarian Representative in the EMA: From Now on there Might be Annual Vaccination against COVID-19

"From now on, there is talk of a one-time, annual vaccination against COVID-19, similar to the seasonal flu vaccine", said on bTV Prof. Ilko Getov, our country's representative in the European Medicines Agency.

Improved Pfizer Vaccine, which will Affect Omicron, will be Ready No Earlier than March

The improved Pfizer vaccine, which will also affect Omicron, will be ready no earlier than March 2022. That's what Pfizer's CEO said. The aim is to vaccinate against covid once a year, and not to have booster doses over a short period of time.

"What I'm hoping for is to have a vaccine that will have to be given once a year - just like many other vaccines," he said.

Prof. Ilko Getov: Bulgarians will have Access to Anti-Covid Drugs in Tablet Form

Breakthrough in drugs against COVID-19 by oral administration, in tablet form. At this stage we have two such molecules - one is molnupiravir, the other ritonavir. This was commented in "The day begins" Prof. Ilko Getov, Bulgarian representative in the European Medicines Agency.

Clinical trials have been conducted that show the drugs have excellent efficacy, he said.

Pages